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Abstract: This placebo-controlled, double-blind, randomized, interventional study investigated the 
effects of low/intermediate doses of n-3 polyunsaturated fatty acids (PUFAs) on the endothelial 
function, markers of leukocyte activation, and oxidative status following dietary intake of n-3 
PUFA-enriched hen eggs in young healthy individuals. Twenty young healthy adults of both sexes 
who consumed n-3 PUFA-enriched hen eggs (two eggs per day, for three weeks, total of 
approximately 407 mg/day n-3 PUFAs) or regular eggs (two eggs per day for three weeks, total of 
approximately 75 mg/day n-3 PUFAs) participated in this study. Skin microvascular endothelium-
independent and endothelium-dependent vasodilation were assessed by laser Doppler flowmetry. 
Serum lipid profile and content of free fatty acids, markers of leukocyte activation, biochemical 
parameters of oxidative stress, as well as antioxidative enzymes serum activity were measured 
before and after respective dietary protocol. The results of this study revealed significant differences 
in the markers of leukocyte activation (such as CD11a/LFA-1) and antioxidative defense, which are 
related to increased intake of n-3 PUFAs, providing the evidence that consumption of nutritionally 
enriched hen eggs may affect physiological processes related to oxidative balance. The absence of 
significant changes in microvascular reactivity following supplementation with a low-intermediate 
dose of n-3 PUFAs, unlike in our previous studies where functional eggs contained ~1 g of n-3 
PUFA, suggests the existence of a dose-dependent effect. 
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1. Introduction 
Evidence from multiple experimental, epidemiological, and clinical studies indicate that n-3 
polyunsaturated fatty acids (n-3 PUFAs) may exert their cardiovascular (CV) protective effect, at least 
in part, by improving vascular endothelium-dependent function [1–3]. These changes occur by n-3 
PUFAs modulation of synthesis of endothelium-derived vasoactive mediators (e.g., NO, COX, and/or 
CYP450 metabolites), modulation of oxidative stress level, endothelial activation, endothelium-
leukocyte interaction, and subsequent endothelial inflammation [1,3–6]. Previously, we demonstrated 
the significant beneficiary effect of consumption of n-3 PUFA-enriched hen eggs on microvascular 
endothelium-dependent reactivity, even in young healthy individuals [7]. These beneficiary effects 
were possibly underlined by modulation of pro-inflammatory and anti-inflammatory factors that can 
influence microvascular reactivity and are produced from n-3 PUFAs [7]. 
By changing membrane composition and fluidity directly via specific receptors, saturated and 
unsaturated fatty acids may influence the regulatory and effector functions of innate and adaptive 
immune cells [8]. It is well-documented that n-3 PUFAs have immune-modulatory effects in innate 
immunity, particularly macrophages. n-3 PUFAs are able to blunt M1 macrophage polarization upon 
lipopolysaccharide (LPS) stimulation and to promote M2 polarization [9]. Additionally, n-3 PUFAs 
alter secretion of pro-inflammatory and anti-inflammatory cytokines, such as TNF-α, IL-1β, and IL-
6, while increasing IL-10 secretion in raw and THP-1-derived macrophages cell lines, as well as in 
culture of primary cell macrophages (as reviewed in [9]). However, both n-6 or n-3 PUFAs are 
sensitive to oxidative stress and easily peroxided [10]. Oxidative stress influences the activity of 
enzymes that metabolize n-3 and n-6 PUFAs and may modify production of pro-inflammatory or 
anti-inflammatory metabolites [11]. On the other hand, n-3 PUFAs metabolites may decrease ROS 
and NO production in LPS-stimulated macrophages [12], associated with decreased activation of 
transcription factors involved in the pro-inflammatory responses. 
One of the unresolved issue with n-3 PUFAs consumption is the threshold dose necessary to be 
consumed to observe these vascular and immune-modulatory effects. The majority of previous 
studies utilized daily doses above one gram of n-3 PUFAs in durations from several weeks to several 
months. For example, in patients with increased CV risk or existing CV disease, these consumed 
amounts were 1 g to 3.7 g of EPA and/or DHA for 6 to 17 weeks [13–16]. In our previous studies, 
consumed doses of n-3 PUFAs in enriched eggs were 770 and 1051 mg/day for 21 days, respectively 
[7,17]. Since such high intake of eggs or supplements is not likely in real-life circumstances, the 
present study aimed to establish the threshold dose for endothelial function modulation and to assess 
the markers of leukocyte activation and oxidative status (such as biochemical parameters of lipid 
peroxidation and anti-oxidative enzymes activity) in a randomized, double-blind, controlled 
prospective study in young healthy participants of both sexes. 
2. Materials and Methods 
2.1. Participants and Study Design 
This was a randomized, double-blind, placebo-controlled interventional study (registration on 
ClinicalTrials.gov Identifier: NCT02720250). Twenty young healthy individuals were recruited to 
participate in this study, including 9 women and 11 men. All volunteers were initially examined to 
determine if they met the inclusion criteria, including (a) age of subjects ranging between 18 and 30 
years, (b) body mass index (BMI) within the normal range (18.5–24.9), as well as normal values of (c) 
arterial BP and (d) serum lipids. Individuals with a positive history of smoking, hypertension, 
coronary artery disease, diabetes, hyperlipidemia, renal impairment, cerebrovascular and peripheral 
artery disease, or taking any drugs or substances that could affect the endothelium were excluded 
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from the study. Study protocol consisted of a dietary intervention during the period of three weeks 
(21 day) in which the subjects were instructed to eat two hen eggs per day (total of 42 eggs provided 
by the investigators), and of two study visits (on day 1 and 21) during which blood sampling and 
functional measurements were performed (described in the following Sections 2.3–2.10). Participants 
were randomly assigned to one of the two study groups: (1) n-3 PUFA group (n = 11) in which subjects 
received n-3 PUFA-enriched hen eggs (approximately 407 mg of n-3 PUFAs per day), or control 
group (n = 9) in which the subjects were provided with regular hen eggs (approximately 75 mg of n-
3 PUFAs per day). Subjects were instructed to eat eggs boiled for about 10 min prior to consumption, 
and were asked not to take additional eggs or n-3 PUFAs supplementation in any form prior to 
enrolment or during when the study protocol study was performed in the Laboratory for Clinical 
and Sport Physiology, Department of Physiology and Immunology at Faculty of Medicine, 
University of Osijek. All participants signed a written informed consent. The study protocol and 
procedures conformed with the standards set by the latest revision of the Declaration of Helsinki and 
were approved by the Ethical Committee of the Faculty of Medicine, University of Osijek (Cl: 602-
04/14-08/06; No: 2158-610714-114). 
2.2. Functional Eggs Production and Fatty Acids Content 
n-3 PUFA-enriched hen eggs and the regular eggs were produced and provided by the Faculty 
of Agrobiotechnical Sciences, University of Osijek, who developed and standardized the production 
protocols. In short, the common sunflower oil in laying hen feeding mixtures was replaced by a 
mixture of fish (1.33%), linseed (1.33%), rapeseed (1.33%), and soybean (1%) oil [7]. The composition 
of fatty acids in the feeding mixture used for the production of regular and n-3 PUFA-enriched eggs 
is shown in Table 1. As a result of changing the fatty acid content in the feeding mixture, hen eggs 
reduced n-6 PUFAs and increased n-3 PUFA concentration with more favorable n-6/n-3 PUFAs ratio 
(Table 1). The fatty acid profile of hens’ feeding mixture and the edible parts of eggs was determined 
according to the method of Csapo et al. [17], and the procedure was described in detail in our 
previously published paper [7]. Gas chromatography was performed on a Bruker 430-GC apparatus 
(Billerica, MA, USA), equipped with a FAMEWAX (RESTEK, Bellefonte, PA, USA) type capillary 
column (30 m × 0.32 mm internal diameter, 0.25-μm film) and flame ionization detector. To identify 
individual fatty acids in the chromatogram, a fatty acid standard mixture Supelco 37 Component 
FAME Mix (Supelco Inc., Bellefonte, PA, USA) was used. Fatty acids profiles of edible parts of regular 
and n-3 PUFA-enriched eggs (mg/100 g edible part) are described in Table 1. Each n-3 PUFA egg 
(average weight 60 g) contained on average 203 mg of n-3 PUFAs (ALA 100 mg/egg, EPA 11 mg/egg, 
DHA 91 mg/egg). Each control egg (average weight 60 g), produced on the same farm, contained on 
average 38 mg of n-3 PUFAs (ALA 12 mg/egg, EPA 6 mg/egg, DHA 20 mg/egg). 
Table 1. Fatty acid profile of hens’ feeding mixture and edible parts of regular (consumed by controls) 
and n-3 PUFA-enriched eggs (consumed by n-3 PUFAs group). 
 
Feeding Mixture (n = 3)  
(g/100 g Total Fatty Acids) 
Eggs (n = 10) (mg/100 g Egg 1) 
Fatty acid 
For production of 
regular eggs 
For production of n-3 
PUFA-enriched eggs 
Regular 
eggs 
n-3 PUFA-
enriched eggs 
∑SFA 21 ± 0.8 17 ± 0.3 * 3107 ± 104 2192 ± 71 * 
∑MUFA 27 ± 1.4 * 37 ± 1.2 4091 ± 180 2980 ± 174 * 
∑n-6 PUFA 49 ± 1.8 33 ± 1.5 * 1775 ± 270 1397 ± 153 
LA 42 ± 2.5 33 ± 1.2 * 1551 ± 258 1302 ± 146 
AA n.d. 0.04 ± 0.01 197 ± 15 79 ± 10 * 
∑N-3 PUFA 3.47 ± 0.69 * 14 ± 1.88 75 ± 4 * 403 ± 49 
ALA 3.33 ± 0.70 * 11.9 ± 1.97 23 ± 2.9 * 198 ± 55 
EPA n.d. 0.63 ± 0.06 12 ± 2.0 * 22 ± 3.2 
DHA 0.14 ± 0.02 * 0.93 ± 0.05 39 ± 3.5 * 180 ± 14 
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∑n-6/n-3 
PUFA 
14.07 2.44 * 23.79 3.46 * 
Data are presented as mean ± standard deviation (SD). n—number of analysis; ∑SFA—saturated fatty 
acids (C14:0, C15:0, C16:0, C17:0, C18:0, C20:0, C21:0, C23:0); ∑MUFA—monounsaturated fatty acids 
(C14:1, C16:1, C18:1n9t, C18:1n9c, C20:1n9, C22:1n9); ∑n-6 PUFA—polyunsaturated fatty acids 
(C18:2n6c, C18:3n6, C20:3n6, C20:4n6, C22:2n6); LA—linoleic acid (C18:2n6c); AA—arachidonic acid 
(C20:4n6); ∑n-3 PUFA—polyunsaturated fatty acids (C18:3n3, C20:3n3, C20:5n3, C22:6n3); ALA—
alpha linolenic acid (C18:3n3); EPA—eicosapentaenoic acid (C20:5n3); DHA—docosahexaenoic acid 
(C22:6n3); n.d—non-detected. 1 edible part; * p < 0.05 control vs. N-3 PUFAs. 
2.3. Anthropometric, Body Composition, Body Fluid Status, and Arterial Blood Pressure Measurement 
Subjects’ weight, height, and hip and waist circumference were measured, and waist-to-hip 
(WHR) ratio and body mass index (BMI) were calculated using appropriate formulas. A four-terminal 
portable impedance analyzer (Maltron Bioscan 920-II, Maltron International Ltd., Rayleigh, Essex, 
UK) was used to measure body fluid status and body composition, by which software and 
empirically derived formulas estimated fat% (fat mass%), fat free mass% (FFM%), extracellular 
water% (ECW%), intracellular water% (ICW%), total body water% (TBW%), interstitial fluid (IF), 
plasma fluid (PF), and body density (kg/L) were calculated. Blood pressure (BP) and heart rate (HR) 
were measured using an automated oscillometric sphygmomanometer (OMRON M3, OMRON 
Healthcare Inc., Osaka, Japan) in a seated position. The final values of BP and HR were the mean of 
three repeated measurements. 
2.4. Assessment of Forearm Skin Microvascular Reactivity 
Forearm skin post-occlusive reactive hyperaemia (PORH), which is a microvascular response to 
vascular occlusion and microvascular reactivity response to iontophoresis of acetylcholine (ACh) 
(endothelium-dependent vasodilation) and sodium nitroprusside (SNP) (endothelium-independent 
vasodilation), were measured by laser Doppler flowmetry (LDF) (MoorVMS-LDF, Axminster, UK). 
Microcirculatory blood flow was expressed in arbitrary perfusion units and determined by software 
calculating the area under the curve (AUC). The final result for the PORH test was expressed as the 
difference between percentage of flow change during reperfusion and occlusion in relation with 
baseline (R-O%), and for SNP or ACh iontophoresis test as a blood flow increase following SNP or 
ACh administration in relation to baseline flow (SNP or ACh blood flow increase). LDF 
measurements were performed in a temperature-controlled room. General procedures for 
performing LDF PORH test and LDF iontophoresis of ACh and SNP tests were done in accordance 
with our well-established protocols, which are described in detail in previous papers of our research 
group [18–20]. 
2.5. Venous Blood Biochemical Analysis 
A venous blood samples for the analysis described in this and further Sections 2.5–2.10 were 
taken after 15 min resting in a seated position at each visit. Blood samples were analyzed for full 
blood count, plasma electrolytes (calcium, sodium, potassium), urea, creatinine, urates, transferrin, 
iron, fasting lipid panels [total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL), 
and high-density lipoprotein cholesterol (HDL)], apolipoprotein A (apoA) and apolipoprotein B 
(apoB), high sensitivity C reactive protein (hsCRP), and fasting blood glucose using standard 
laboratory methods. Described analyses were performed at the Department of Clinical Laboratory 
Diagnostics, University Hospital Osijek. 
2.6. Profiling of Plasma Fatty Acid Concentrations 
Profiling of plasma fatty acids concentrations was done in the Radiation Chemistry and 
Dosimetry Laboratory, Division of Materials Chemistry, Ruđer Bošković Institute (IRB), Zagreb, 
Croatia, according to previously described protocol [21]. Total lipids were extracted from plasma and 
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treated with 0.5 M KOH/MeOH (Merck, Germany) to induce formation of the fatty acid methyl esters 
(FAMEs). Gas chromatography was used for FAMEs extraction and analysis. Individual fatty acids 
were determined in plasma samples and expressed as relative percentages of FAME obtained from 
total lipid extract. The percentage of FAME (a relative amount of each fatty acid) was quantified by 
integrating the area under the peak and dividing the results by the total area for all fatty acids [21]. 
2.7. Measurement of Thiobarbituric Acid Reactive Substances (TBARS) and Ferric-Reducing Ability of 
Plasma (FRAP) 
Spectrophotometry measurement of the thiobarbituric acid reactive substances (TBARS), which 
are products of lipid peroxidation and presents the measure of oxidative stress, and the ferric-
reducing ability of plasma (FRAP), which presents the measure of antioxidant capacity, were done in 
all participants before and after respective diet protocol according to the previously described 
protocol from our laboratory [22,23]. 
2.8. Measurement of Glutathione Peroxidase 1 (GPx1) and Superoxide Dismutase (SOD) Serum Activity 
As a measure of antioxidant potential, the serum activity of antioxidant enzymes superoxide 
dismutase (SOD) and glutathione peroxidase (GPx) were measured before and after respective diet 
protocol using previously established methods by our research group [22,24,25]. GPx activity was 
determined indirectly by measuring the rate of nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidation to NADP+, accompanied by a decrease in absorbance at 340 nm over 5 min. Total 
SOD activity was measured as the degree of inhibition of reduction of cytochrome C by a superoxide 
radical. Enzyme activity assays were performed using a Lambda 25UV-Vis spectrophotometer 
equipped with UV WinLab 6.0 software package (PerkinElmer For the Better, Waltham, MA, USA). 
Measured activities of all investigated enzymes were expressed as U (mg protein)-1. 
2.9. Measurement of Plasma Lipid Hydroperoxides (LOOH) Concentration 
Plasma lipid hydroperoxides (LOOH) presents another biochemical marker of oxidative stress 
level. Lipids extraction in plasma samples was performed as previously described [26]. The 
concentrations of LOOH were calculated using the molar absorptivity of the complex [FeNCS]2+ 
formed per mol of LOOH, 58,440 M−1 cm−1, at 500 nm [27,28]. Measurements were performed in the 
Laboratory for Radiation Chemistry and Dosimetry, Ruđer Bošković Institute, Zagreb, Croatia. 
2.10. Flow Cytometry 
In order to assess activation status of peripheral blood leukocyte subpopulations, cell surface 
expression of LFA-1 (CD11a/CD18) integrin, as well as frequencies of CD11a baring leukocyte subsets 
were determined by flow cytometry. Venous blood samples were collected in tubes containing EDTA 
at concentration of 1.8 mg EDTA per milliliter of blood, and immediately processed for cell-surface 
staining. One-hundred μL of whole blood was stained and incubated with a mixture of antibodies (50 
μL per sample) for 30 min at room temperature in the dark. Prior to the addition of antibody mixture, 
nonspecific binding was blocked by addition of 5 uL Fc block reagent and 10 min of incubation at room 
temperature (Human BD Fc Block, BD Pharmingen, San Jose, CA, USA). The antibody mixture 
consisted of CD14 FITC (clone: 61D3, eBioscience, San Diego, CA, USA), CD45-PerCP (clone: MEM-28, 
EXBIO, Vestec, Czech Republic), biotinylated CD11a/LFA-1 (clone: HI111, eBioscience, San Diego, CA, 
USA), and CD16 APC (clone: eBioCB16, eBioscience, San Diego, CA, USA. Visualization of the 
biotinylated antibody was performed by an additional staining step with streptavidin coupled with 100 
μL PE-Cy7 (BD Biosciences, San Jose, CA, USA) on room temperature for 30 min in the dark. 
Erythrocytes were lysed by cell incubation with 1x BD™ FACS™ Lysing Solution for 10 min on 37 °C. 
After the last washing step with 1 × PBS, cells were fixated with 1% formaldehyde. At least 10,000 target 
cells were collected by a BD FACSCanto II cytometer (FACSCanto II, Becton Dickinson, San Jose, CA, 
USA) and analyzed using the FlowLogic software (Inivai Technologies, Mentone, Australia). 
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2.11. Statistical Analysis 
All results are reported as the arithmetic mean ± standard deviation (SD). The Kolmogorov–
Smirnov normality test was used to assess the distribution of the acquired data. Within group 
analysis was performed using the Wilcoxon rank-sum test in the case when variables were not 
normally distributed or a paired student’s t-test for normally distributed data. All results were 
additionally compared by one-way ANOVA or Kruskal–Wallis test, followed by Holm–Sidak or 
Dunn’s post hoc test, respectively. The correlations between functional data or biochemical blood 
analysis data and corresponding immunological parameters were determined by Spearman’s or 
Pearson’s correlation tests when appropriate. p < 0.05 was considered statistically significant. For 
statistical. analysis the SigmaPlot, version 11.2 (Systat Software, Inc., Chicago, IL, USA) was used. 
3. Results 
3.1. Patients Characteristics, Hemodynamic and Biochemical Parameters 
All participants completed a 3-week dietary protocol. All participants were normotensive and 
lean, had normal renal function, full blood count, serum electrolytes, iron, transferrin, hsCRP, fasting 
blood glucose, and fasting lipid levels (Table 2). Age, anthropometric, and hemodynamic parameters 
(e.g., age, BMI, WHR, BP and HR) were not significantly different at the moment of entering the study 
protocol between participants who comprised control and n-3 PUFAs group (Tables 2 and 3). Sodium 
and HDL cholesterol were significantly higher, and triglycerides significantly lower in n-3 PUFAs 
group compared to control group at the moment of entering the study protocol (Table 2); however, 
all values were within normal population range. Values of other biochemical parameters at the 
moment of entering the study protocol between the participants in control and n-3 PUFAs groups 
were similar (Table 2). 
BP, HR, and biochemical values in control and n-3 PUFAs group before and after respective 
protocol are presented in Table 2. BP and HR were similar after dietary protocol compared to baseline 
(initial) measurements within n-3 PUFAs or control group. Also, the values of SBP, MAP, DBP, and 
HR were similar between control and n-3 PUFAs group following corresponding diet protocol. 
Hemoglobin and hematocrit values were significantly increased after dietary intake of regular 
hen eggs compared to initial measurement in control group. Thrombocyte level significantly 
increased, and fasting blood glucose significantly decreased at the end of dietary protocol compared 
to initial measurement in n-3 PUFAs group. Transferrin level significantly increased in both control 
and n-3 PUFAs group following respective diet protocol compared to baseline measurement. 
However, all values (hemoglobin, hematocrit, thrombocyte, and transferrin) were within 
physiological range. There were no significant differences in erythrocytes and leukocytes number, as 
well as serum urea, creatinine, urates, electrolytes, iron, hsCRP, and fasting lipid panel concentrations 
after n-3 PUFAs enriched or regular eggs consumption compared to baseline conditions within the 
groups, or compared between the groups. 
Table 2. Cardiovascular and biochemical characteristics of study population before and after 
consumption of regular (control group) or n-3 PUFA-enriched hen eggs (n-3 PUFAs group). 
Parameter 
Control Group n-3 PUFA Group 
Before After Before After 
N (W/M) 9 (2/7) 11 (7/4) 
Age (years) 21 ± 2 21 ± 2 
SBP (mmHg) 124 ± 12 122 ± 10 117 ± 10 118 ± 8 
DBP (mmHg) 78 ± 9 75 ± 10 75 ± 9 77 ± 7 
MAP (mmHg) 93 ± 9 91 ± 9 89 ± 9 90 ± 6 
HR (beats per minute) 75 ± 16 68 ± 11 72 ± 15 71 ± 10 
erythrocytes (× 1012/L) 4.9 ± 0.4 5.0 ± 0.5 4.8 ± 0.5 4.8 ± 0.5 
hemoglobin (g/L) 144 ± 12 148 ± 14 * 139 ± 14 139 ± 13 
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hematocrit (%) 42.3 ± 3.8 43.9 ± 4.0 * 41.7 ± 3.8 42.2 ± 3.9 
leukocytes (× 109/L) 7.3 ± 1.1 7.2 ± 1.6 7.5 ± 1.6 8.2 ± 1.3 
thrombocytes (× 109/L) 231 ± 36 258 ± 39 266 ± 69 289 ± 75 * 
urea (moll/L) 5.7 ± 1.4 5.5 ± 1.4 5.4 ± 1.5 5.4 ± 1.4 
creatinine (μmoll/L) 83 ± 15 80 ± 16 79 ± 13 79 ± 14 
urates (μmoll/L) 343 ± 27 332 ± 41 298 ± 76 291 ± 69 
sodium (moll/L) 138 ± 2 137 ± 2 140 ± 2 † 139 ± 2 
potassium (moll/L) 4.1 ± 0.2 4.1 ± 0.3 4.3 ± 0.2 4.4 ± 0.5 
calcium (moll/L) 2.4 ± 0.1 2.5 ± 0.1 2.4 ± 0.1 2.5 ± 0.1 
iron (μmoll/L) 16 ± 5 17 ± 6 18 ± 8 15 ± 9 
transferrin (g/L) 2.5 ± 0.3 2.7 ± 0.3 * 2.7 ± 0.2 3.0 ± 0.4 * 
glucose (moll/L) 5.2 ± 0.6 4.9 ± 0.7 4.9 ± 0.4 4.4 ± 0.4 * 
hsCRP (mg/L) 1.7 ± 2.8 0.6 ± 0.4 1.6 ± 2.3 1.2 ± 1.0 
cholesterol (moll/L) 4.0 ± 0.7 4.2 ± 0.3 4.5 ± 0.8 4.6 ± 0.8 
triglycerides (moll/L) 1.1 ± 0.3 † 1.1 ± 0.6 0.7 ± 0.3 0.9 ± 0.5 
HDL cholesterol (moll/L) 1.4 ± 0.2 1.4 ± 0.2 1.7 ± 0.4 † 1.7 ± 0.4 
LDL cholesterol (moll/L) 2.1 ± 0.5 2.3 ± 0.2 2.3 ± 0.4 2.4 ± 0.5 
apoA (g/L) 1.6 ± 0.2 1.6 ± 0.2 1.8 ± 0.3 1.7 ± 0.3 
apoB (g/L) 0.6 ± 0.1 0.7 ± 0.1 0.7 ± 0.1 0.7 ± 0.1 
Data are presented as mean ± standard deviation (SD). N—number of participants; W—women; M—
men; SBP—systolic blood pressure; MAP—mean arterial pressure; DBP—diastolic blood pressure; 
HR—heart rate; hsCRP—high-sensitivity C reactive protein; LDL—low-density lipoprotein; HDL—
high-density lipoprotein; apoA—apolipoprotein A1; apoB—apolipoprotein B. * p < 0.05 control vs. n-
3 PUFAs; † p < 0.05 before vs. after within control or n-3 PUFAs group. 
3.2. Anthropometric Measures, Body Fluid Status, and Body Composition 
BMI, WHR, body fluid status, and body composition in control and n-3 PUFAs group before and 
after respective protocol are described in Table 3. Despite randomization in assignment to groups, at 
baseline, control group had significantly higher FFM% and body density compared to n-3 PUFAs 
group. Hence, at baseline n-3 PUFAs group had significantly higher fat% than controls. This 
difference in fat% was lost after dietary protocols. WHR, BMI, FFM%, ECW%, ICW%, TBW%, IF, PF, 
or Body Density were not affected by dietary protocols in both control and n-3 PUFAs group (Table 
3). BMI, WHR, body fluid status, and body composition were similar between control and n-3 PUFAs 
group following corresponding diet protocol. 
Table 3. Anthropometric Measures, Body Fluid Status and Body Composition Responses to Regular 
(Control Group) or n-3 PUFAs Enriched Hen Eggs Consumption (n-3 PUFAs Group). 
Parameter 
Control Group n-3 PUFAs Group 
Before After Before After 
BMI (kg/m2) 24.4 ± 2.3 24.3 ± 2.3 25.2 ± 3.7 25.0 ± 4.2 
WHR 0.80 ± 0.02 0.80 ± 0.02 0.79 ± 0.04 0.77 ± 0.04 
Fat Free Mass (%) 83.6 ± 7.7 * 83.0 ± 7.9 75.1 ± 7.6 75.3 ± 8.8 
Fat (%) 16.4 ± 7.5 17.0 ± 7.9 24.9 ± 7.6 * 24.7 ± 8.8 
Total Body Water (%) 62.9 ± 8.7 61.6 ± 7.5 56.0 ± 7.0 55.8 ± 7.6 
Extracellular Water (%) 43.8 ± 2.8 43.0 ± 1.4 42.7 ± 1.5 42.8 ± 1.8 
Intracellular Water (%) 56.2 ± 2.8 57.0 ± 1.4 57.3 ± 1.5 57.2 ± 1.8 
Plasma Fluid (L) 4.61 ± 0.98 4.44 ± 1.07 3.79 ± 0.98 3.79 ± 1.22 
Body Density (kg/L) 1.061 ± 0.015 * 1.060 ± 0.020 1.043 ± 0.017 1.043 ± 0.020 
Values are mean ± SD. BMI—body mass index; WHR—waist-to-hip ratio. * p < 0.05 Control vs. n-3 PUFAs. 
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3.3. Plasma Fatty Acid Concentrations 
Dietary intake of n-3 PUFA-enriched eggs did not significantly change plasma fatty acids profile 
compared to baseline measurements in n-3 PUFAs group (Table 4). Intake of regular eggs 
significantly decreased plasma concentration of oleic acid (C18:1; n-9 PUFA) compared to baseline 
measurement in control group. Also, at baseline measurement, oleic acid plasma concentration was 
significantly higher in control than in n-3 PUFAs group. There were no other significant differences 
in plasma fatty acid concentrations compared within the groups, or compared between the groups 
(Table 4). 
Table 4. Serum fatty acid profile changes in response to regular (control group) or n-3 PUFA-enriched 
hen eggs consumption (n-3 PUFAs group). 
Parameter 
Control Group (n = 9) Omega-3 Group (n = 11) 
Before After Before After 
%SFA (%FAME) 36.7 ± 2.2 33.9 ± 10.2 36.9 ± 1.8 29.3 ± 11.7 
%MUFA (%FAME) 23.2 ± 5.1 24.7 ± 10.0 19.4 ± 2.1 28.1 ± 14.9 
%PUFA (%FAME) 40.6 ± 5.5 41.3 ± 5.5 43.6 ± 2.8 42.6 ± 4.8 
SFA (%FAME)     
C14:0 Myristic acid 0.82 ± 0.74 1.31 ± 0.76 1.02 ± 0.34 1.30 ± 0.57 
C16:0 Palmitic acid 25.8 ± 2.9 25.5 ± 3.3 26.6 ± 1.6 27.0 ± 2.5 
C18:0 Stearic acid 10.1 ± 2.0 10.2 ± 3.8 9.5 ± 1.1 9.3 ± 1.2 
MUFA and PUFA (%FAME)     
C16:1 (n-7) Palmitoleic acid 1.21 ± 0.76 1.49 ± 0.55 1.24 ± 0.28 1.40 ± 0.65 
C18:1 (n-7) Vaccenic acid 1.24 ± 0.72 1.67 ± 0.31 1.29 ± 0.18 1.38 ± 0.24 
C18:1 (n-9) Oleic acid 20.7 ± 4.6 †* 18.4 ± 2.4 16.6 ± 2.1 16.9 ± 2.8 
C18:2 (n-6) Linoleic acid 30.3 ± 4.9 30.4 ± 4.3 34.0 ± 2.9 32.8 ± 4.1 
C20:3 (n-6) Dihomo-gamma-linolenic acid 1.46 ± 0.73 1.51 ± 0.73 1.74 ± 0.91 1.69 ± 0.73 
C20:4 (n-6) Arachidonic acid 7.0 ± 2.4 7.7 ± 1.6 6.8 ± 1.5 6.8 ± 1.6 
C18:3 (n-3) α-Linolenic acid 1.04 ± 1.86 * 0.61 ± 1.1.10 0 ± 0 0.08 ± 0.18 
C20:5 (n-3) Eicosapentaenoic acid 0 ± 0 0 ± 0 0 ± 0 0 ± 0 
C22:6 (n-3) Docosahexaenoic acid 0.85 ± 0.86 1.14 ± 0.26 0.91 ± 0.48 1.09 ± 0.66 
n-6/n-3 PUFA 20.5 22.6 46.7 35.3 
Results are expressed as mean ± standard deviation (SD). %FAME—fatty acid methyl esters; MUFA—
monounsaturated fatty acids; SFA—saturated fatty acids; PUFA—polyunsaturated fatty acids. * p < 
0.05 control vs. n-3 PUFAs; † p < 0.05 before vs. after within control or n-3 PUFAs group. 
3.4. Acetylcholine-Induced Dilation, Sodium Nitroprusside-Induced Dilation, and Post-Occlusive Reactive 
Hyperaemia in Forearm Skin Microcirculation 
Consumption of regular or n-3 PUFA-enriched eggs did not significantly change PORH, AChID, 
or SNPID compared to baseline measurement in control and n-3 PUFAs group, respectively 
(Supplementary Materials Figure S1). Also, values of PORH, AChID, and SNP were similar between 
the groups, before and after respective diet protocol (Figure S1). 
3.5. Markers of Oxidative Stress and Antioxidative Defence 
A three-week dietary consumption of n-3 PUFA-enriched eggs significantly decreased FRAP in 
n-3 PUFAs group compared to baseline (Table 5), while FRAP remained unchanged following regular 
eggs consumption after dietary protocol in the control group. TBARS level was significantly higher 
in n-3 PUFAs than in control group at baseline, as well as after completion of respective egg 
consumption protocol. However, TBARS was not significantly affected by both n-3 PUFAs or regular 
egg consumption compared to baseline within the groups. 
Consumption of n-3 PUFAs enriched eggs significantly increased SOD serum activity in n-3 
PUFAs group compared to baseline (Table 5, Figure 1), while it remained unchanged following 
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regular eggs consumption compared to baseline in control group. SOD serum activity was similar 
between the groups. GPx serum activity was not significantly changed after n-3 PUFAs or regular 
egg consumption compared to baseline within the groups, just as GPx serum activity was similar 
between the groups. 
LOOH plasma concentration was not significantly changed by either n-3 PUFAs or regular egg 
consumption compared to baseline within the groups, just as LOOH plasma concentration was 
similar between the groups (Table 5). 
Table 5. Lipid peroxidation (TBARS and LOOH), antioxidant capacity (FRAP), and antioxidative 
enzyme (GPx and SOD) activity responses to regular (control group) or n-3 PUFA-enriched hen eggs 
consumption (n-3 PUFAs group). 
Parameter 
Control Group n-3 PUFAs Group 
Before After Before After 
TBARS (μM 
MDA) 
23.5 ± 0.6 24.1 ± 2.1 26.7 ± 2.6 * 26.1 ± 2.8 * 
FRAP (mM 
Trolox) 
0.47 ± 0.06 0.48 ± 0.05 0.46 ± 0.07 0.42 ± 0.08 † 
GPx (U/mg 
protein) 
3.83 × 10−3 ± 0.7 × 
10−3 
3.45 × 10−3 ± 0.5 × 
10−3 
3.59 × 10−3 ± 0.4 × 
10−3 
4.04 × 10−3 ± 0.9 × 
10−3 
SOD (U/mg 
protein) 
0.11 ± 0.05 0.10 ± 0.02 0.06 ± 0.06 0.10 ± 0.10 † 
LOOH (μM) 1.46 ± 0.66 1.35 ± 0.51 1.30 ± 0.65 1.10 ± 0.47 
FRAP—Ferric reducing ability of plasma; TBARS—thiobarbituric acid reactive substances; SOD—
superoxide dismutase; GPx—glutathione peroxidase; LOOH—lipid hydroperoxide. * p < 0.05 control 
vs. n-3 PUFAs (t test); † p < 0.05 before vs. after within control or n-3 PUFAs group (one-way ANOVA). 
3.6. Interrelation of Vascular Measurements, Markers of Oxidative Balance, and Leukocyte Activation 
Additional analysis revealed significant association of individual oxidative status markers and 
BMI, frequencies of peripheral blood leukocyte subsets and CD11a/LFA-1 expression levels. Namely, 
in the control group, a significant negative correlation between TBARS and CD11a/LFA-1 expression 
on monocytes was found (r = −0.678, p = 0.011; Figure 1), while in n-3 PUFAs group, TBARS was 
increasing together with increasing BMI levels (r = 0.462, p = 0.039; Table 6). In the n-3 PUFAs group, 
SOD activity correlated negatively to frequencies of peripheral blood granulocytes (r = −0.590, p = 
0.001; Figure 1) and BMI (r = −0.548, p = 0.039; Table 6), while SOD activity and peripheral blood 
monocyte frequencies correlated positively (r = 0.534, p = 0.015; Figure 1, Table 6). 
In the case of control group, we additionally found a significant positive association between 
CD11a/LFA-1 expression on granulocytes or monocytes and forearm skin microvascular response to 
iontophoresis of acetylcholine (r = 0.556, p = 0.038 or r = 0.541, p = 0.043; Figure S1). 
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Figure 1. Correlation of oxidative status markers and peripheral blood leukocyte subpopulations or 
CD11a expression. Levels of lipid peroxidation negatively correlated to CD11a expression monocytes 
in Control group (A), while in the n-3 PUFA group SOD activity negatively and positively correlated 
to frequencies of peripheral blood granulocytes (B) and monocytes (C), respectively. Correlation 
coefficient (r) was calculated using Pearson product-moment correlation. p < 0.05 was considered 
significant. Control group—young healthy volunteers subjected to 14-day diet with regular hen eggs; 
n-3PUFA group—young healthy volunteers subjected to 14-day diet with n-3 PUFA-enriched hen 
eggs. PUFA—Polyunsaturated Fatty Acids, CD11a—Cluster of Differentiation 11a, integral part of 
integrin Lymphocyte Function-Associated Antigen 1 (LFA-1), TBARS—Thiobarbituric Acid Reactive 
Substances, MDA—Malondialdehyde, SOD—Superoxide Dismutase. 
Table 6. Body mass index correlates to frequencies of peripheral blood monocytes and markers of 
oxidative balance. 
 Control Group n-3 PUFAs Group 
 Body Mass Index (kg/m2) 
 r =  p =  r =  p =  
Rate of peripheral blood monocytes (%) −0.684 0.010 * −0.468 0.039 * 
FRAP (mM Trolox) 0.092 0.717 0.534 0.015 * 
TBARS (μM MDA) 0.113 0.654 0.462 0.039 * 
SOD activity (U/mg protein) −0.052 0.839 −0.548 0.028 * 
GPx activity (U/mg protein) −0.066 0.793 −0.376 0.146 
LOOH(μM) −0.252 0.313 −0.098 0.665 
Pearson correlation coefficient was calculated, * p < 0.05 was considered significant. FRAP—Ferric 
reducing ability of plasma; TBARS—thiobarbituric acid reactive substances; SOD—superoxide 
dismutase; GPx—glutathione peroxidase; LOOH—lipid hydroperoxide. 
3.7. Peripheral Blood Leukocyte Subpopulations and CD11a (LFA-1) Integrin Expression 
At the end of the dietary protocols, frequencies of peripheral blood monocytes and granulocytes 
in both groups remained the same and were similar between the groups. Interestingly, in both 
groups, frequencies of peripheral blood monocytes negatively correlated to BMI (Figure 2). The rate 
of CD11a bearing leukocytes among CD45+ blood cells was in the range between 99 and 100%, and 
the rate of CD11a positive monocytes, granulocytes or lymphocytes did not change significantly upon 
the dietary protocol (Tables S1 and S2). At the end of dietary protocol, both groups presented with 
significantly reduced expression of LFA-1/CD11a integrin on the peripheral blood granulocytes 
(control group 1307.5 ± 392.3 vs. 707.8 ± 197.5; p = 0.005; Figure 2C and n-3 PUFAs group 982.2 ± 227.44 
vs. 776.8 ± 177.91; p = 0.005; Figure 2C) when compared to the respective baseline levels. In addition, 
n-3 PUFAs group exhibited monocytes deactivation, as evidenced by significantly reduced 
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CD11a/LFA-1 expression compared to baseline values (904.4 ± 644.6 vs. 473.0 ± 162.4; p = 0.024; Figure 
2C). CD11a/LFA-1 expression was similar between the two groups at baseline or after the dietary 
protocols. 
Peripheral blood monocytes were additionally analyzed for classical (CD14++CD16−), 
intermediate (CD14++CD16++), and non-classical (CD14+CD16++) subsets, and we found 
significantly reduced frequency of classical monocytes in the n-3 PUFAs group after the dietary 
protocol (p = 0.039; Figure 2D) with a slight (but not statistically significant) shift towards the 
intermediate subset. 
 
Figure 2. Effects of regular and n-3 PUFA-enriched eggs consumption on the LFA-1 (CD11a) integrin 
expression. The gating strategy is shown in panel (A). Representative histograms demonstrating 
CD11a integrin expression on granulocytes and monocytes in negative control samples (grey), at 
baseline (red), and after respective dietary protocol (green) are shown in panel (B). Expression levels 
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of CD11a integrin on granulocytes and monocytes are demonstrated in panel (C), while average 
frequencies of peripheral blood monocytes, classical (CD14++CD16−), intermediate (CD14++CD16++), 
and non-classical monocytes (CD14+CD16++) are demonstrated in panel (D). Data are presented as 
arithmetic mean and standard deviation; within group differences were tested using the Wilcoxon 
rank-sum test or paired student’s t-test, while between group differences were compared using one-
way ANOVA or Mann–Whitney U test, p < 0.05 were considered significant. Control group—young 
healthy volunteers subjected to 14-day diet with regular hen eggs; n-3 PUFAs group—young healthy 
volunteers subjected to 14-day diet with n-3 PUFA-enriched hen eggs. SSC-A—Side scatter, FSC-A—
Forward Scatter, CD11a, PUFA—Polyunsaturated Fatty Acids, CD11a—Cluster of Differentiation 
11a, integral part of integrin Lymphocyte Function-Associated Antigen 1 (LFA-1), PE-Cy7-A—
fluorescence tandem dye consisting of R-phycoerythrin (PE) and Cyanine-7 (Cy7). 
4. Discussion 
In the present study, we investigated the effects of a diet enriched with low doses of n-3 PUFAs 
on the microvascular function, oxidative status, and antioxidative capacity, as well as the expression 
of leukocyte inflammation markers in young healthy individuals. Based on our results, daily 
consumption of two fortified hen eggs (~407 mg n-3 PUFAs) was insufficient to induce significant 
changes in serum concentrations of n-3 and n-6 PUFAs or the skin microvascular reactivity. However, 
we found a small but significant immunomodulatory effect of hen eggs consumption independent of 
n-3 PUFAs content, in respect of reduced integrin CD11a/LFA-1 expression on the populations of 
peripheral blood monocyte and granulocyte accompanied by a shift from classical to intermediate 
monocyte subsets, suggesting a decrease in pro-inflammatory phenotype and deactivation of 
leukocyte subpopulations. These effects were more pronounced in group receiving n-3 PUFA-
enriched than regular hen eggs. 
Surprisingly, although the subjects were recruited among young, healthy, normal weight 
individuals matched by sex and age, their random assignment to two experimental groups resulted 
in the significantly higher body fat composition in the n-3 PUFAs group and discrete changes in 
oxidative balance, suggesting pro-oxidative state related to the body fat content. This was supported 
by a significant association between BMI and markers of oxidative balance, which is probably present 
due to the higher level of lipid peroxidation in those individuals (as evidenced by TBARS levels). 
Interestingly, consumption of n-3 PUFA-fortified eggs resulted in compensatory increase in SOD 
activity in the same group, the effect of which was not observed in control group. 
4.1. n-3 PUFA Enriched Hen Eggs Effects on Microvascular Functional Responses 
In the present study, microvascular reactivity was not significantly affected by any kind of hen 
eggs consumption. This contrasts with our previous findings of enhanced microvascular dilator 
responses in young individuals who consumed n-3 PUFA-enriched hen eggs [7,29]. However, this 
difference may be contributed to the low dose of ingested n-3 PUFAs (approximately 406 mg/day for 
three weeks in the present study, compared to 770 or 1050 mg/day in previous studies). Improved 
endothelium-dependent vasodilation in response to acetylcholine was reported in healthy 
individuals who took fish oil supplementation (EPA+DHA) of approximately 250 mg/day for eight 
months [30]. In an effort to determine cut-off values of n-3 PUFAs supplementation from which their 
beneficial effects on endothelial function may begin to emerge, in this particular study we tested if 
supplementation of 406 mg n-3 PUFAs daily in a form of functional food would induce functional 
improvement of forearm skin microvascular function, as evidenced in our earlier study [7,29]. Taken 
together, the cut-off values of dietary intake of n-3 PUFAs may be set at >750 mg per day, during at 
least three weeks in order to observe beneficial functional changes in the microcirculation of young 
healthy individuals. 
4.2. n-3 PUFA-Enriched Hen Eggs, Blood Pressure Level, and Serum Lipid Profile 
Most studies reporting that n-3 PUFAs intake has the potential to induce clinically relevant 
reduction in BP level were done in patients with essential hypertension, in patients with untreated 
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hypertension, and in normotensive but mildly hypercholesterolemic individuals [31–34]. However, 
such a significant effect of n-3 PUFAs intake in a form of fish servings (∼800 mg/serving EPA+DHA; 
four servings a week for eight weeks) or supplementation as fish oil capsules (two grams/day 
EPA+DHA for 12 weeks; 1.7 g/day EPA+DHA for four weeks) in lowering BP level was not observed 
in normotensive individuals [35–37]. Interestingly, two studies reported significantly decreased BP 
level following consumption of n-3 PUFA-enriched hen eggs in healthy individuals (770 mg/day for 
three weeks [29,38]; four eggs/day for four weeks). In the present study, consumption of n-3 PUFA-
enriched hen eggs did not significantly affect BP levels. 
Furthermore, in the present study no significant changes in serum lipid profile (triglycerides, 
total cholesterol, LDL cholesterol, and HDL cholesterol) following consumption of n-3 PUFA-
enriched hen eggs in healthy individuals were observed. Clinical studies and meta-analysis in 
hyperlipidemic individuals reported that n-3 PUFAs supplementation (EPA and DHA) can reduce 
serum lipids, most notably triglycerides [1]. Moreover, consumption of n-3 PUFA-enriched 
functional food (e.g., hen eggs) has the potential to decrease serum triglycerides level (for 
approximately 16–18%) in healthy individuals [29,38–40]. Altogether, current evidence indicate that 
n-3 PUFA intake has potential to decrease serum triglycerides level in both hyperlipidemic and 
normolipidemic individuals, but obviously, there is a threshold amount of n-3 PUFAs that needs to 
be consumed to observe these effects. 
4.3. Modulation of Oxidative Stress and Antioxidative Capacity by n-3 PUFA-Enriched Diet 
Antioxidant enzymes, such as glutathione peroxidase (GPx), superoxide dismutase (SOD), and 
catalase (CAT), serve as a primary defense system against oxidative stress [41–48]. Although these 
scavenger enzymes at first are inactivated when counteracting ROS, their expression is induced by 
the presence of reactive species [41]. Lower levels of serum SOD in hypertensive and diabetic subjects 
are negatively correlated with most of the vascular functional and structural parameters [49]. Subjects 
suffering from diabetes and lipid profile impairment exhibit low antioxidant activity of SOD and GPx 
[50,51]. 
Our participants were young healthy individuals with no relevant impairments or disease 
history that could alter antioxidative activity or serum levels of observed enzymes. Serum levels of 
SOD significantly increased in n-3 PUFAs group after the protocol, which suggests beneficial effect 
of n-3 PUFAs on this defense system. On the other hand, observed increases in SOD activity may be 
a compensation for a decrease in plasma antioxidative capacity (measured by FRAP) in n-3 PUFAs 
group. SOD scavenges oxygen radicals and inhibits lipid peroxidation, thus preventing detrimental 
effects of oxidative stress in vasculature [52]. This may explain why lipid peroxidation products in 
plasma of n-3 PUFAs group were not affected by dietary protocol. In the early phases of lipid 
peroxidation, as a result of fatty acid oxidation, lipid hydroperoxides (LOOH) are formed. 
Interestingly, we did not observe changes in LOOH products related to dietary protocol. LOOH are 
generated from PUFAs and represent primarily products of fatty acid peroxidation, while 
malondialdehyde presents an end product of lipid peroxidation and is often measured as 
thiobarbituric acid reactive substances (TBARS) [53]. LOOHs may give epoxy-allylicperoxyl radicals 
(OLOO·) by undergoing iron-mediated electron reduction and oxygenation [53]. Additional 
protection from iron-induced oxidative stress is provided by transferrin, which binds extracellular 
iron [54]. Although within physiological range, transferrin was significantly increased after both 
dietary protocols in the present study. It is interesting that activation of M1 macrophages is associated 
with reduction of ferroportin and upregulation of iron storage protein H ferritin, which leads to iron 
retention and inflammation [55]. In the present study, we observed decreased frequency of classical 
monocytes but increased transferrin with n-3 PUFAs dietary intake, which supports the hypothesis 
that transferrin participates in antioxidative defense and is also employed by n-3 PUFAs. 
In our study, plasma antioxidative capacity was slightly, but significantly decreased in n-3 
PUFAs group after dietary protocol compared to baseline levels. This may be related to unchanged 
activity of plasma GPx and increased plasma lipid peroxidation end-products at the beginning of the 
protocol. Furthermore, BMI correlates negatively with SOD and GPx activity in n-3 PUFAs group. In 
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addition, participants in n-3 PUFAs group had significantly increased fat%, which positively 
correlated with TBARS, suggesting that fat body content can be a source of increased oxidative stress 
in these participants. 
4.4. Supplementation with Intermediate Doses of n-3 PUFAs Deactivates Circulating Leukocytes at 
Comparable Levels to Regular Eggs 
There is an accumulating amount of evidence that dietary consumption of n-3 PUFAs can 
favorably modify immune processes and lower the risk of cardiovascular events and mortality for 
individuals who consume increased amounts of DHA and EPA [56]. It seems that the 
immunomodulatory effects of n-3 PUFAs are more easily observed and traced if the human clinical 
trials involve subjects with pre-existing conditions [56,57]. One of the most prominent changes 
observed is the reduction in endothelium-leukocyte interactions, which results in preventing the 
initiation and slowing the progress of atherosclerosis [57]. n-3 PUFAs (including EPA and DHA, as 
well as their oxidized metabolites) can decrease the expression of key adhesion molecules, such as 
intercellular adhesion molecule (ICAM)-1), vascular cell adhesion molecule (VCAM)-1 or E-Selectin 
on the surface of endothelial cells (as reviewed in [57]). Integrins (CD11/CD18, VLA-4) on leukocytes 
interact with immunoglobulin-like adhesion molecules (e.g., ICAM, VCAM-1) on endothelial cells, 
thus mediating firm adhesion and subsequent trans-endothelial migration of leukocytes [58]. Upon 
in vitro TNF alpha-induced human umbilical vein endothelial cells activation, preincubation of these 
cells with EPA or DHA resulted in reduced rolling and adherence of monocytes on activated 
endothelial cells without affecting CAMs expression. This was further related to the suppressed 
generation of endothelial platelet-activating factor (PAF) [59]. In the present study, we found 
evidence for leukocyte deactivation, possible through reduced endothelial activation characterized 
by downregulation of CAMs and inflammatory mediators. However, in the control group that 
followed the diet with regular hen eggs, similar effects were also observed. This could be attributed 
to the under-recognized anti-oxidative properties of hen eggs. Namely, beside their exceptional 
nutritive value, and overestimated atherogenic effects, hen eggs are very rich in antioxidants like 
ovalbumin, ovotransferrin, ovomucin, lysozyme, cystatin, carotenoids, vitamin E, etc. [60]. 
Furthermore, it has been found that lysozyme from hen egg white ameliorates LPS-induced systemic 
inflammation in mice [61]. Sethi S et al. showed that the treatment with oxidized EPA, but not native 
EPA, diminished LPS-induced surface expression of E-selectin, VCAM-1, and ICAM-1 in a dose 
dependent manner, suggesting an important role for oxidized metabolites of n-3 PUFAs [62]. 
Furthermore, it was shown that DHA can promote the resolution of inflammation by facilitating 
efferocytosis through M2 macrophage polarization, and this was linked to n-3 PUFA-induced PPAR 
γ activation [63]. 
Unlike the CD11a/LFA-1 expression on leukocytes that was observed in both groups consuming 
regular or n-3 PUFA-fortified hen eggs, in the case of monocyte subsets distribution, there was n-3 
PUFA-related decrease in classical CD14++CD16—monocytes accompanied by a shift towards 
intermediate CD14++CD16++ monocytes. This is in line with a study on lipoprotein receptor deficient 
mice (LDLr−/−) fed a diet rich in fish oil, which exhibited significantly reduced plasma cholesterol 
levels, frequency of splenic Ly6Chi (classical) monocytes, atherosclerosis, monocyte trafficking into 
the aortic root, and atherosclerotic lesion macrophage content [64]. Similar research performed on 
humans with hypertriglyceridemia showed reduced fasting triglyceride levels and decreased 
proportions of intermediate monocytes [65]. Arnardottir HH et al. reported that the proportion of 
classical monocytes in the blood of healthy mice was decreased upon dietary fish oil consumption, 
but their proportion was increased upon induction of inflammation, thus enhancing microbial 
defense [66]. 
Oxidative stress may promote monocyte recruitment in human diseases. For example, H2O2 
was shown to serve as chemoattractant to monocytes [67], while peroxynitrate enhances expression 
of VCAM, P-selectin, and E-selectin on endothelial cells in a process possibly mediated by heme 
oxygenase-1 (HO-1) regulation [68]. Vice versa, activated endothelial cells produce ROS, which by 
activating oxidant-sensitive transcription factors (AP-1, NFkB), promotes transcription of CAMs [69]. 
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A decrease in oxidative stress and intracellular ROS level of human monocytes, reduced their 
migration and adhesion [70]. In the present study, positive association between SOD activity and the 
frequency of peripheral blood monocytes was found. This would suggest that the increased SOD 
activity may compensate for increased inflammation, e.g., decreased monocyte activation and 
extravasation. One interesting finding of this study was the negative correlation between the BMI 
and frequency of peripheral blood monocytes. This is in contrast to previous reports of a positive 
association between CD56+ monocytes and body fat, body mass index, waist circumference, C-
reactive protein, triglycerides, and HbA1c in obese individuals [71]. A possible explanation for 
observed discrepancies is that the BMI of our participants was in the range for normal weight. 
5. Conclusions 
In the present study, we have showed that a three-week dietary protocol with a daily 
consumption of two fortified hen eggs (~410 mg/day n-3 PUFAs) had a negligible effect on the serum 
concentrations of n-3 and n-6 PUFAs, and had no effect on the skin microvascular reactivity. While 
this provides additional evidences for the safety of hen eggs consumption in terms of atherogenic 
effects and cardiovascular risk, results of this study also suggested that the minimal dose of n-3 
PUFAs in the dietary protocols aiming to improve microvascular and endothelial function should be 
higher. Based on our recently published studies and available literature, n-3 PUFA dose should range 
from 750 mg to 1 g. 
Here, we also demonstrated a small but significant immunomodulatory effect of hen egg 
consumption in respect to reduced integrin CD11a/LFA-1 expression on monocyte and granulocyte 
populations accompanied by a shift from classical to intermediate monocyte subsets. These effects 
were slightly more pronounced in low-dose n-3 PUFA-fortified eggs. The proposed n-3 PUFAs’ 
mediated effects on the microcirculation are summarized in Figure 3. 
A limitation of this study was that the participants recruited to the n-3 PUFAs group had slightly 
(not significantly) higher body mass index, which was in the normal range; however, this had resulted 
in significantly higher body fat composition in the n-3 PUFAs group. The same group showed 
significant correlation of BMI and markers of oxidative balance, which is probably due to higher levels 
of lipid peroxidation in those individuals. Interestingly, consumption of low-dose n-3 PUFA-fortified 
eggs resulted in increased SOD activity, which insufficiently compensated to the observed reduction of 
FRAP (a measure of total antioxidative capacity); however, positive association between SOD activity 
and the frequency of peripheral blood monocytes suggest that the increased SOD activity may 
compensate for increased inflammation, e.g., decrease monocyte activation and extravasation. 
Nevertheless, future studies should be directed toward the functional status of the immune cells, 
e.g., it is possible to speculate that reduced frequencies of classical monocytes are related to a shift 
from primarily pro-inflammatory, ROS-mediated phagocytic response to antigen presentation, 
immune regulation, or antibody/complement-mediated effector function. Additionally, assessment 
of oxidative status of leukocyte subpopulations would be an important link between the 
cardioprotective effects of n-3 PUFAs consumption and low-grade inflammation affecting 
endothelial function, which is observed in all cardiometabolic diseases. 
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Figure 3. Dose-dependent effects of n-3 PUFAs on microcirculation. N-3 PUFAs can modulate 
oxidative balance by increasing activity of oxidative enzymes and reducing lipid peroxidation (a), 
and thereby prevent e-NOS uncoupling and improve/restore endothelial function in cardiovascular 
patients (b). Several previous functional studies demonstrated reduced endothelium-leukocyte 
interactions and a subsequent lower level of leukocyte extravasation (c). N-3 PUFAs outcompete n-6 
PUFAs for the integration into the cell membrane, and as a result of these structural changes of the 
membrane, the products of lipoxygenase and cyclooxygenase pathway are anti-inflammatory 
mediators, such as resolvins, prostaglandin E3, and leukotriene B5 (d). In addition, n-3 PUFA 
attenuate endothelial activation trough PPAR activation-mediated NFκB inhibition (e). eNOS—
endothelial nitric oxide synthase; NFκB—nuclear factor kappa-light-chain-enhancer of activated B 
cells; PPAR—Peroxisome proliferator-activated receptor PUFA—Polyunsaturated Fatty Acids, 
GPx—Glutathione Peroxidase; SOD—Superoxide Dismutase; AA—Arachidonic Acid; EPA—
Eicosapentaenoic Acid; DHA—Docosahexaenoic Acid. 
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